Diabeloop develops AI-powered automated insulin delivery systems to personalize and automate Type 1 diabetes treatment.
Diabeloop is a company focused on automating and personalizing the treatment of Type 1 diabetes. They have developed a self-learning algorithm that incorporates therapeutic artificial intelligence to manage the condition. This technology aims to reduce the daily burden of therapeutic decisions for individuals with Type 1 diabetes, allowing them to focus less on their condition and more on their lives. The company actively involves patients in the development of its innovations, ensuring that solutions are intuitive and inspired by real-world experiences. Diabeloop's first medical device is available in France and several other European countries, and they are expanding internationally through partnerships with companies like Roche Diabetes Care, ViCentra, SOOIL, Terumo Corporation, and Novo Nordisk. Their DBLG2 algorithm has received FDA clearance and CE marking.
Integrations: Roche Diabetes Care, ViCentra, SOOIL, Terumo Corporation, BIOCORP, EOFlow, Novo Nordisk, Dexcom G6
Platforms: Web
View full Diabeloop profile on Tools-Radar | Browse Healthcare tools | Alternatives to Diabeloop
Tools-Radar is a free directory of 10,000+ AI tools — discover, compare, and choose the right AI software for your needs. Visit tools-radar.com